Lamivudine
114957
Phase 1 small_molecule completed
Quick answer
Lamivudine for Hepatitis B, Chronic is a Phase 1 program (small_molecule) at GlaxoSmithKline with 1 ClinicalTrials.gov record(s).
Program details
- Company
- GlaxoSmithKline
- Indication
- Hepatitis B, Chronic
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed